WSTAM
NAGE

Wilbanks Smith & Thomas Asset Management’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$86K – 1349
2018
Q3 		$86K Buy
+20,000
New +$86K 0.01% 577